Compound information
- Natural Products
- ZC2162619
- Molecular Formula
- C13H9F3N2OS
- Molecular Weight
- 298.038768568 g/mol
- Structure
-
- IUPAC Name
- N-[4-[2-(trifluoromethyl)thiazol-4-yl]phenyl]prop-2-enamide
- InChI
- InChI=1S/C13H9F3N2OS/c1-2-11(19)17-9-5-3-8(4-6-9)10-7-20-12(18-10)13(14,15)16/h2-7H,1H2,(H,17,19)
- InChI Key
- KYSSEGMJJRADQW-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(-c2csc(C(F)(F)F)n2)cc1
- Source
- ZINC001262556383
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 41.99 Å2 | LogP | 3.897 |
LogS | -4.762 | LogD | 3.981 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.019 | Pgp substrate | 0.001 |
HIA | 0.959 | F20 % | 0.993 |
F30 % | 0.971 | Caco-2 | -4.399 |
MDCK | -4.908 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.007 | PPB | 93.651 |
VD | 0.935 | Fu | 1.646 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.996 | CYP1A2 substrate | 0.686 |
CYP2A6 substrate | 0.669 | CYP2B6 substrate | 0.698 |
CYP2C19 inhibitor | 0.882 | CYP2C19 substrate | 0.898 |
CYP2C8 substrate | 0.708 | CYP2C9 inhibitor | 0.777 |
CYP2C9 substrate | 0.997 | CYP2D6 inhibitor | 0.037 |
CYP2D6 substrate | 0.917 | CYP2E1 substrate | 0.615 |
CYP3A4 inhibitor | 0.02 | CYP3A4 substrate | 0.98 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.202 | CL | 9.347 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.008 | Hepatotoxicity | 0.993 |
Mutagenicity | 0.96 | Rat Oral Acute Toxicity | 0.723 |
FDAMDD | 0.575 | Skin Sensitization | 0.31 |
Carcinogenicity | 0.107 | Eye Corrosion | 0.004 |
Eye Irritation | 0.293 | Respiratory Toxicity | 0.798 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.057 | IGC50 | 3.926 |
LC50FM | 5.885 | LC50DM | 6.382 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.545 | NR-AR-LBD | 0.394 |
NR-AhR | 0.734 | NR-Aromatase | 0.449 |
NR-ER | 0.781 | NR-ER-LBD | 0.75 |
NR-PPAR-gamma | 0.953 | SR-ARE | 0.918 |
SR-ATAD5 | 0.77 | SR-HSE | 0.783 |
SR-MMP | 0.971 | SR-p53 | 0.908 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.